<DOC>
	<DOC>NCT03098797</DOC>
	<brief_summary>A randomized double-blind cross over trial to evaluate the safety, efficacy and tolerability of elamipretide in subjects with Barth Syndrome.</brief_summary>
	<brief_title>A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Barth Syndrome</mesh_term>
	<criteria>Genetically confirmed Barth Syndrome Male aged 12 and above At the screening visit, eGFR must meet the following: 1. Body weight &gt;30 kg AND eGFR &gt; 90mL/min at screening 2. Body weight &gt;40kg AND eGFR &gt;60 but &lt;90mL/min at screening Ambulatory and impaired during the 6MWT On stable medication for 30 days prior to the baseline visit Participated in another interventional clinical trial within 30 days of or is currently enrolled in a noninterventional clinical trial at the baseline visit potentially confounding with this trial Prior or current medical condition that would prevent the subject from safely participating in the trial Undergone any inpatient hospitalizations within 30 days of the baseline visit Is undergoing an apparent pubertal growth spurt Has uncontrolled hypertension History of substance abused within the year before the baseline visit or is likely to be uncompliant History of heart transplantation or current placement on the waiting list for a heart transplant For subjects with an ICD: known occurrance of ICD discharge in the 3 months prior to the baseline visit For subjects without an ICD: expected to undergo an implantation of an ICD during the conduct of the study Currently receiving treatment with chemotherapeutic agents or immunosuppressant agents or has received prior radiation therapy to the chest Recipient of stem cell or gene therapy or is currently being treated by a therapeutic investigational device</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Barth Syndrome</keyword>
	<keyword>elamipretide</keyword>
	<keyword>MTP-131</keyword>
	<keyword>Stealth</keyword>
	<keyword>Stealth BT</keyword>
	<keyword>BTHS</keyword>
</DOC>